Abstract
Biologically active compounds with potential anticancer activity have been isolated from various animal sources. Recent research is focused on venoms from animal sources, since they specifically target cancer cells and are less toxic to normal tissues, thus making them a better alternative for prevention and management of cancer. Animals produce pharmacologically active compounds that are capable of protein synthesis inhibition, induction of angiogenesis and apoptosis. Over the past decades, venom has been identified as a potential source of therapeutic agents, including anti-cancer agents. Venoms are isolated from various animal sources such as wasp, honey bee and scorpion are composite mixtures of various peptides, protein, enzymes, toxins and non-proteinaceous secretions. They are natural compounds that act as a template and can be utilized for the development of new therapeutic agents against cancer. The objective of this review is to create a comprehensive resource of anticancer agents from venoms which would foster pharmacogenomic studies and the development of cost-effective cancer treatment. Information about different animal venoms has been compiled after a panoramic literature survey.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Peptide Research and Therapeutics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
